Cargando…
Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
BACKGROUND: Although the BNT162b2 COVID-19 vaccine is known to induce IgG neutralizing antibodies in serum protecting against COVID-19, it has not been studied in detail whether it could generate specific immunity at mucosal sites, which represent the primary route of entry of SARS-CoV-2. METHODS: S...
Autores principales: | Azzi, Lorenzo, Dalla Gasperina, Daniela, Veronesi, Giovanni, Shallak, Mariam, Ietto, Giuseppe, Iovino, Domenico, Baj, Andreina, Gianfagna, Francesco, Maurino, Vittorio, Focosi, Daniele, Maggi, Fabrizio, Ferrario, Marco Mario, Dentali, Francesco, Carcano, Giulio, Tagliabue, Angelo, Maffioli, Lorenzo Stefano, Accolla, Roberto Sergio, Forlani, Greta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718969/ https://www.ncbi.nlm.nih.gov/pubmed/34954658 http://dx.doi.org/10.1016/j.ebiom.2021.103788 |
Ejemplares similares
-
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine
por: Azzi, Lorenzo, et al.
Publicado: (2023) -
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients
por: Azzi, Lorenzo, et al.
Publicado: (2021) -
Reply to the Letter to the Editor: “Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?
por: Azzi, Lorenzo, et al.
Publicado: (2022) -
Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly
por: Dalla Gasperina, Daniela, et al.
Publicado: (2023) -
Saliva is a reliable tool to detect SARS-CoV-2
por: Azzi, Lorenzo, et al.
Publicado: (2020)